EUVIMEDEUVIMED entdecken
Crossref

Emerging LncRNA HOTAIR and NME1 polymorphisms in ovarian cancer risk: A pilot case–control study in South Indian women

Harshavardhani Canchi Sistla, Arun Seshachalam, Krishna Kumar Rathnam, Taruna Rajagopal, Srikanth Talluri, Nageswara Rao Dunna

Clinica Chimica Acta · 2026-06 · 588 · 120995

DOI: 10.1016/j.cca.2026.120995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2026-06. Verfasst von Harshavardhani Canchi Sistla und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genomics & Molecular Oncology Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanj…. Hauptthemen laut MEDLINE: NM23 Nucleoside Diphosphate Kinases, RNA, Long Noncoding, Ovarian Neoplasms, Genetic Predisposition to Disease. Die Arbeit nennt 29 Literaturangaben. Gefördert von: SASTRA Deemed University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Long non-coding RNAs (lncRNAs) are increasingly recognized as clinically relevant regulators of cancer susceptibility, progression, and therapeutic response. However, the contribution of low-penetrance genetic variants affecting lncRNAs and metastasis suppressor genes to ovarian cancer (OC) risk remains incompletely defined. In this population-based case-control study, we evaluated the genetic and clinical relevance of polymorphisms in HOTAIR (rs1899663, rs920778) and NME1 (rs2302254, rs16949649) in South Indian women for the first time. MATERIALS & METHODS A total of 494 subjects (240 OC patients and 254 age-matched controls) were enrolled. Genomic DNA was isolated from peripheral whole blood, and genotyping was performed using the PCR-RFLP method. Logistic regression models were applied to estimate OC risk, while linkage disequilibrium (LD), haplotype, and clinicopathological correlation analyses were conducted to assess combined genetic effects on the disease susceptibility. RESULTS Both HOTAIR variants showed significant associations with increased OC susceptibility. Carriers of the rs1899663 G/T and T/T genotypes exhibited 2.88- and 2.23-fold elevated risk, respectively (p < 0.001), while the rs920778 C/C genotype conferred a 2.24-fold increased risk (p = 0.006). NME1 rs2302254 was also strongly associated with OC risk, particularly the T/T genotype (OR = 3.79; p < 0.0001), whereas rs16949649 showed no significant effect. Clinically, rs920778 correlated with tumor stage and age at onset, and rs2302254 was associated with advanced disease stage. Gene-specific haplotype analysis revealed significant associations for HOTAIR (T-C and T-T) and NME1 (T-T and C-T) haplotypes with OC risk (global p < 0.001), although LD between variants within each locus was weak, suggesting largely independent allelic contributions. CONCLUSION Overall, these findings suggest that HOTAIR and NME1 polymorphisms may contribute to genetic susceptibility in OC and warrant further investigation and functional validation in larger, well-characterized cohorts for their potential utility as biomarkers for risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NM23 Nucleoside Diphosphate KinasesRNA, Long NoncodingOvarian NeoplasmsGenetic Predisposition to DiseasePolymorphism, Single NucleotideHumansFemaleCase-Control StudiesMiddle AgedIndiaPilot ProjectsAdult

Stichwörter der Autor:innen

Gene variantsHOX transcript antisense intergenic RNALong non-coding RNAsMetastasis suppressor geneNucleoside diphosphate kinase 1nm23

Substanzen

NM23 Nucleoside Diphosphate KinasesRNA, Long NoncodingNME1 protein, humanHOTAIR long untranslated RNA, human

Autor:innen und Institutionen

  • Cancer Genomics & Molecular Oncology Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur 613401, India.
  • Department of Medical and Paediatric Oncology, Dr. G.V.N Cancer Institute, Riverside, Trichy 620 005, India.
  • Department of Hemato Oncology - Medical Oncology and Bone Marrow Transplantation, Meenakshi Mission Hospital & Research Centre, Madurai 625107, India.
  • Department of Biotechnology, Sona College of Arts and Science, Salem 636005, India.
  • Dana Farber Cancer Institute, Boston, MA 02215, USA.
  • Cancer Genomics & Molecular Oncology Laboratory, Department of Biotechnology, School of Chemical and Biotechnology, SASTRA - Deemed University, Thanjavur 613401, India. Electronic address: dnrao@biotech.sastra.edu.

Förderung

  • SASTRA Deemed University

Zitieren

APA

Sistla, H. C., Seshachalam, A., Rathnam, K. K., Rajagopal, T., Talluri, S., & Dunna, N. R. (2026). Emerging LncRNA HOTAIR and NME1 polymorphisms in ovarian cancer risk: A pilot case–control study in South Indian women. Clinica Chimica Acta, 588, 120995. https://doi.org/10.1016/j.cca.2026.120995

Vancouver

Sistla HC, Seshachalam A, Rathnam KK, Rajagopal T, Talluri S, Dunna NR. Emerging LncRNA HOTAIR and NME1 polymorphisms in ovarian cancer risk: A pilot case–control study in South Indian women. Clinica Chimica Acta. 2026;588:120995. doi:10.1016/j.cca.2026.120995

BibTeX
@article{Sistla2026,
  author = {Sistla, Harshavardhani Canchi and Seshachalam, Arun and Rathnam, Krishna Kumar and Rajagopal, Taruna and Talluri, Srikanth and Dunna, Nageswara Rao},
  title = {Emerging LncRNA HOTAIR and NME1 polymorphisms in ovarian cancer risk: A pilot case–control study in South Indian women},
  journal = {Clinica Chimica Acta},
  year = {2026},
  volume = {588},
  pages = {120995},
  doi = {10.1016/j.cca.2026.120995}
}
Kostenlos starten →